Results 91 to 100 of about 4,750 (178)

Linezolid-related Optic Nerve Disorders: Insight From a Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System. [PDF]

Open Forum Infect Dis
Nakano Y, Miyazaki M, Fukuyama A, Hasuwa H, Imakyure O.   +4 more
europepmc   +1 more source

Genetic Characterization of a Linezolid- and Penicillin-Resistant <i>Enterococcus hirae</i> Isolate Co-Harboring <i>poxtA</i> and <i>pbp5fm</i>. [PDF]

Transbound Emerg Dis
Huang J, Li A, Wang M, Gu S, Hu H, Wang X, Wang L.   +6 more
europepmc   +1 more source

Real-world evidence on predictors of antimicrobial resistance among patients with chronic liver disease. [PDF]

Front Med (Lausanne)
Kandasamy G, Selvaraj L, Orayj K, Almanasef M, Asiri R, Alzaydani A, Assiri RA, Srikanth D, Ravikumar JK.   +8 more
europepmc   +1 more source

Diastereospecific Synthesis of Vicinally Substituted 2-Oxazolidinones via Oxidative Rearrangement of α,β-Unsaturated γ-Lactams. [PDF]

J Org Chem
Lidskog A, Li Y, Gupta AK, Mishra A, Sundin A, Wärnmark K.   +5 more
europepmc   +1 more source

Characterization of multiresistance gene optrA in Bacillus subtillis from China. [PDF]

J Antimicrob Chemother
Che Y, Jiang J, Wu R, Wang L, Wu X, Chen Q, Chen R, Zhou L.   +7 more
europepmc   +1 more source

Oxazolidinones

, 2017
openaire   +1 more source

Health Technology Assessment of Oxazolidinones for MRSA-Associated Complicated Skin and Soft Tissue Infections. [PDF]

Drug Des Devel Ther
Zhao Y, Huang B, Yang Z, Kuang H, Chen J.   +4 more
europepmc   +1 more source

Improved Radiosynthesis of [¹⁸F]-Labeled Oxazolidinone Antibiotics for Future Clinical Translation. [PDF]

ACS Infect Dis
Sarhan M, Shelke AM, Mane K, Jadhav R, Jeon B, Nino-Meza O, Chen X, Freundlich JS, Jain SK, Carroll L.   +9 more
europepmc   +1 more source

Magnetically recyclable Fe3O4@SiO2 supported phosphonium ionic liquids for efficient and sustainable transformation of CO2 into oxazolidinones

Green Processing and Synthesis
Hu Yu Lin, Zhang Qiu Yun, Zhang Yu Tao
doaj   +1 more source

panTB-HM: a multi-arm clinical trial of a pan-TB regimen targeting both host and microbe. [PDF]

Trials
Mudzengi D, Mashatole S, Xiang Q, Adrion C, Glover N, Ngwanto T, Mdluli J, Boniface S, Rassool M, Matome B, Paramo L, Svensson E, Fasanmi A, Angelo S, Moyo M, Marx C, Khosa C, Mokaba L, Mofokeng N, Lalashowi J, Lalashowi J, Nacy C, Charalambous S, Fumane E, Maphossa V, Beattie T, Brumskine W, Venter C, Mapamba D, Heinrich N, Rajaram S, Kooverjee S, Botha L, Nell M, Easton A, Foraida S, Warren RM, Sabi I, Ntinginya N, Wallis RS, panTB-HM Consortium.   +40 more
europepmc   +1 more source